Liver International logo Blackwell Publishing logo

Publisher: Blackwell Publishing

Volume 27, Number 9, November 2007
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Treating nonalcoholic fatty liver disease
pp. 1157-1165(9)
Authors: Méndez-Sánchez, Nahum; Arrese, Marco; Zamora-Valdés, Daniel; Uribe, Misael

Percutaneous liver biopsy in clinical practice
pp. 1166-1173(8)
Authors: Al Knawy, Bandar; Shiffman, Mitchell

Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis
pp. 1174-1184(11)
Authors: Itatsu, Keita; Zen, Yoh; Ohira, Shusaku; Ishikawa, Akira; Sato, Yasunori; Harada, Kenichi; Ikeda, Hiroko; Sasaki, Motoko; Nimura, Yuji; Nakanuma, Yasuni

Interferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trials
pp. 1185-1193(9)
Authors: Rudin, Dan; Shah, Sooraj M.; Kiss, Alexander; Wetz, Robert V.; Sottile, Vincent M.

Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis
pp. 1194-1201(8)
Authors: Kalaitzakis, Evangelos; Olsson, Rolf; Henfridsson, Pia; Hugosson, Irene; Bengtsson, Maria; Jalan, Rajiv; Björnsson, Einar

Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients
pp. 1202-1208(7)
Authors: Jiang, Zhijun; Feng, Xiaoning; Zhang, Wu; Gao, Feng; Ling, Qi; Zhou, Lin; Xie, Haiyang; Chen, Qixing; Zheng, Shusen

Similar effects of recombinant interferon-α-2b and natural interferon-α when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular carcinoma
pp. 1209-1216(8)
Authors: Uka, Kiminori; Aikata, Hiroshi; Takaki, Shintaro; Miki, Daiki; Jeong, Soo Cheol; Hiramatsu, Akira; Kodama, Hideaki; Shirakawa, Hiroo; Kawakami, Yoshiiku; Takahashi, Shoichi; Toyota, Naoyuki; Ito, Katsuhide; Chayama, Kazuaki

γ-Glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-α-2b in chronic hepatitis C non-responders
pp. 1217-1225(9)
Authors: Bergmann, Jilling F.; Vrolijk, Jan M.; van der Schaar, Peter; Vroom, Brigitte; van Hoek, Bart; van der Sluys Veer, Annet; de Vries, Richard A.; Verhey, Elke; Hansen, Bettina E.; Brouwer, Johannes T.; Janssen, Harry L. A.; Schalm, Solko W.; de Knegt, Robert J.

Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis
pp. 1226-1231(6)
Authors: Rigopoulou, Eirini I.; Davies, Edward T.; Bogdanos, Dimitrios-Petrou; Liaskos, Christos; Mytilinaiou, Maria; Koukoulis, George K.; Dalekos, George N.; Vergani, Diego

Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension
pp. 1232-1239(8)
Authors: Kemp, William; Krum, Henry; Colman, John; Bailey, Michael; Yandle, Tim; Richards, Mark; Roberts, Stuart

Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation
pp. 1240-1248(9)
Authors: Perry, John F.; Charlton, Barbara; Koorey, David J.; Waugh, Richard C.; Gallagher, P. James; Crawford, Michael D.; Verran, Deborah J.; McCaughan, Geoffrey W.; Strasser, Simone I.

Glycine reduces hepatic warm ischaemia-reperfusion injury by suppressing inflammatory reactions in rats
pp. 1249-1254(6)
Authors: Yamanouchi, Kosho; Eguchi, Susumu; Kamohara, Yukio; Yanaga, Katsuhiko; Okudaira, Sadayuki; Tajima, Yoshitsugu; Kanematsu, Takashi

Hepatic stellate cell line modulates lipogenic transcription factors
pp. 1255-1264(10)
Authors: Guimarães, Eduardo L. M.; Franceschi, Mariana F. S.; Andrade, Cláudia M. B.; Guaragna, Regina M.; Borojevic, Radovan; Margis, Rogério; Bernard, Elena A.; Guma, Fátima C. R.

Leptin stimulates α1(I) collagen expression in human hepatic stellate cells via the phosphatidylinositol 3-kinase/Akt signalling pathway
pp. 1265-1272(8)
Authors: Niu, Liwen; Wang, Xiaohong; Li, Jun; Huang, Yan; Yang, Zhen; Chen, Feihu; Ni, Hongchang; Jin, Yong; Lu, Xiongwen; Cao, Qi

NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells
pp. 1273-1281(9)
Authors: Kohjima, Motoyuki; Enjoji, Munechika; Higuchi, Nobito; Kotoh, Kazuhiro; Kato, Masaki; Takayanagi, Ryoiichi; Nakamuta, Makoto

Successful living donor liver transplantation using a graft from a hepatitis B surface antigen-positive donor
pp. 1282-1286(5)
Authors: Soejima, Yuji; Shimada, Mitsuo; Taketomi, Akinobu; Yoshizumi, Tomoharu; Uchiyama, Hideaki; Ikegami, Toru; Nakamuta, Makoto; Maehara, Yoshihiko

Branched-chain amino acids improve insulin resistance in patients with hepatitis C virus-related liver disease: report of two cases
pp. 1287-1292(6)
Authors: Kawaguchi, Takumi; Taniguchi, Eitaro; Itou, Minoru; Sumie, Shuji; Oriishi, Tetsuharu; Matsuoka, Hisako; Nagao, Yumiko; Sata, Michio

Perivascular epithelioid cell tumour of the liver
pp. 1293-1294(2)
Authors: Fang, Songhua; Zhou, Lina; Jin, Mei; Hu, Jibo

Announcement
pp. 1295-1295(1)

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A